Age Labs has developed EPIPHANY, a machine learning-based biomarker discovery platform for the early detection of diseases and to predict drug response. Their focus on aging and immunology.

Age Labs first diagnostic candidate is a test for the early detection of rheumatoid arthritis. They are also developing biomarkers for COVID-19 severity and for measuring biological age and frailty.